Biorem Inc Stock Analysis
| BRM Stock | CAD 3.00 0.02 0.67% |
BioRem Inc is fairly valued with Real Value of 3.06 and Hype Value of 3.06. The main objective of BioRem stock analysis is to determine its intrinsic value, which is an estimate of what BioRem Inc is worth, separate from its market price. There are two main types of BioRem's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect BioRem's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of BioRem's stock to identify patterns and trends that may indicate its future price movements.
The BioRem stock is traded in Canada on TSX Venture Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. BioRem is usually not traded on Canada Day, Civic Holiday, Labour Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day. BioRem Stock trading window is adjusted to America/Toronto timezone.
BioRem |
BioRem Stock Analysis Notes
The book value of the company was currently reported as 0.43. The company had not issued any dividends in recent years. BioRem Inc had 1:4 split on the 21st of January 2005. BIOREM Inc., an environmental biotechnology company, designs, manufactures, and sells air emissions control systems that are used to eliminate odors, volatile organic compounds , and hazardous air pollutants in Canada, the United States, China, and internationally. In addition, it offers biological processes and testing services media sampling and analysis system review and inspections and media replacements and spare parts. BIOREM INC operates under Pollution Treatment Controls classification in Canada and is traded on TSX Venture Exchange. For more info on BioRem Inc please contact PEng MBA at 519 767 9100 or go to https://www.biorem.biz.BioRem Quarterly Total Revenue |
|
BioRem Inc Investment Alerts
| BioRem Inc had very high historical volatility over the last 90 days | |
| BioRem Inc is unlikely to experience financial distress in the next 2 years | |
| Latest headline from news.google.com: BioRem Third Quarter 2024 Earnings EPS CA0.14 - Yahoo Finance |
BioRem Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 46.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioRem's market, we take the total number of its shares issued and multiply it by BioRem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.BioRem Profitablity
BioRem's profitability indicators refer to fundamental financial ratios that showcase BioRem's ability to generate income relative to its revenue or operating costs. If, let's say, BioRem is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, BioRem's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of BioRem's profitability requires more research than a typical breakdown of BioRem's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.11 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07. | Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.09 | 0.10 | |
| Return On Capital Employed | 0.30 | 0.32 | |
| Return On Assets | 0.09 | 0.10 | |
| Return On Equity | 0.32 | 0.34 |
Management Efficiency
BioRem Inc has return on total asset (ROA) of 0.1461 % which means that it generated a profit of $0.1461 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.5968 %, meaning that it generated $0.5968 on every $100 dollars invested by stockholders. BioRem's management efficiency ratios could be used to measure how well BioRem manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to 0.1 in 2024. Return On Capital Employed is likely to climb to 0.32 in 2024. At this time, BioRem's Other Current Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 3.8 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 1.9 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.43 | 0.45 | |
| Tangible Book Value Per Share | 0.43 | 0.45 | |
| Enterprise Value Over EBITDA | 5.10 | 3.18 | |
| Price Book Value Ratio | 2.33 | 2.89 | |
| Enterprise Value Multiple | 5.10 | 3.18 | |
| Price Fair Value | 2.33 | 2.89 | |
| Enterprise Value | 13.1 M | 9 M |
Leadership effectiveness at BioRem Inc is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin 0.0703 | Profit Margin 0.1135 | Beta 0.851 | Return On Assets 0.1461 | Return On Equity 0.5968 |
Technical Drivers
As of the 30th of November, BioRem shows the Mean Deviation of 2.47, downside deviation of 2.44, and Risk Adjusted Performance of 0.1244. BioRem Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BioRem Inc jensen alpha, as well as the relationship between the potential upside and skewness to decide if BioRem Inc is priced correctly, providing market reflects its regular price of 3.0 per share.BioRem Inc Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BioRem middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BioRem Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
BioRem Outstanding Bonds
BioRem issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioRem Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioRem bonds can be classified according to their maturity, which is the date when BioRem Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
BioRem Predictive Daily Indicators
BioRem intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioRem stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
BioRem Forecast Models
BioRem's time-series forecasting models are one of many BioRem's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioRem's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About BioRem Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how BioRem prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioRem shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BioRem. By using and applying BioRem Stock analysis, traders can create a robust methodology for identifying BioRem entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.11 | 0.12 | |
| Operating Profit Margin | 0.12 | 0.13 | |
| Net Profit Margin | 0.09 | 0.09 | |
| Gross Profit Margin | 0.28 | 0.34 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding BioRem to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Additional Tools for BioRem Stock Analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.